Literature DB >> 11553779

Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen.

O Bruña-Romero1, G González-Aseguinolaza, J C Hafalla, M Tsuji, R S Nussenzweig.   

Abstract

We report that complete protection against malaria and total inhibition of liver stage development and parasitemia was obtained in 100% of BALB/c mice primed with a replication-defective recombinant adenovirus expressing the circumsporozoite (CS) protein of Plasmodium yoelii (AdPyCS), followed by a booster with an attenuated recombinant vaccinia virus, expressing the same malaria antigen, VacPyCS. We found increased levels of activated CS-specific CD8(+) and CD4(+) T cells, higher anti-sporozoite antibody titers, and greater protection in these mice, when the time between priming and boosting with these two viral vectors was extended from 2 to 8 or more weeks. Most importantly, by using this immunization regimen, the protection of the immunized mice was found to be long-lasting, namely complete resistance to infection of all animals 3 1/2 months after priming. These results indicate that immunization with AdPyCS generates highly effective memory T and B cells that can be recalled long after priming by boosting with VacPyCS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553779      PMCID: PMC58757          DOI: 10.1073/pnas.191380898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.

Authors:  Y Takita-Sonoda; M Tsuji; K Kamboj; R S Nussenzweig; P Clavijo; F Zavala
Journal:  Exp Parasitol       Date:  1996-11       Impact factor: 2.011

2.  Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses.

Authors:  K Murata; A García-Sastre; M Tsuji; M Rodrigues; D Rodriguez; J R Rodriguez; R S Nussenzweig; P Palese; M Esteban; F Zavala
Journal:  Cell Immunol       Date:  1996-10-10       Impact factor: 4.868

3.  The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria.

Authors:  M Rodrigues; R S Nussenzweig; F Zavala
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

4.  The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes.

Authors:  M R Briones; M Tsuji; V Nussenzweig
Journal:  Mol Biochem Parasitol       Date:  1996-04       Impact factor: 1.759

5.  Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor, using recombinant vaccinia virus vectors.

Authors:  D Rodriguez; Y W Zhou; J R Rodriguez; R K Durbin; V Jimenez; W T McAllister; M Esteban
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.

Authors:  D Grillot; M Michel; I Müller; C Tougne; L Rènia; D Mazier; G Corradin; P H Lambert; J A Louis; G Del Guidice
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

7.  CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.

Authors:  M M Rodrigues; A S Cordey; G Arreaza; G Corradin; P Romero; J L Maryanski; R S Nussenzweig; F Zavala
Journal:  Int Immunol       Date:  1991-06       Impact factor: 4.823

8.  Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.

Authors:  S Li; M Rodrigues; D Rodriguez; J R Rodriguez; M Esteban; P Palese; R S Nussenzweig; F Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

Authors:  Y Miyahira; K Murata; D Rodriguez; J R Rodriguez; M Esteban; M M Rodrigues; F Zavala
Journal:  J Immunol Methods       Date:  1995-04-12       Impact factor: 2.303

10.  Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.

Authors:  M Rodrigues; S Li; K Murata; D Rodriguez; J R Rodriguez; I Bacik; J R Bennink; J W Yewdell; A Garcia-Sastre; R S Nussenzweig
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

View more
  39 in total

1.  Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.

Authors:  Mieke C Sprangers; Wandena Lakhai; Wouter Koudstaal; Marielle Verhoeven; Björn F Koel; Ronald Vogels; Jaap Goudsmit; Menzo J E Havenga; Stefan Kostense
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Authors:  Nia Tatsis; Julie C Fitzgerald; Arturo Reyes-Sandoval; Kimberly C Harris-McCoy; Scott E Hensley; Dongming Zhou; Shih-Wen Lin; Ang Bian; Zhi Quan Xiang; Amaya Iparraguirre; Cesar Lopez-Camacho; E John Wherry; Hildegund C J Ertl
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

3.  A peptide-based Plasmodium falciparum circumsporozoite assay to test for serum antibody responses to pre-erythrocyte malaria vaccines.

Authors:  Stefan Kostense; Bregje Mommaas; Jenny Hendriks; Mariëlle Verhoeven; Mariska Ter Haak; Felicia Tirion; Edison Wiesken; Maria Grazia Pau; Katarina Radosevic; Jaap Goudsmit
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

4.  Adenovirus vector-induced CD8⁺ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi Infection.

Authors:  José Ronnie Vasconcelos; Mariana R Dominguez; Ramon L Neves; Jonatan Ersching; Adriano Araújo; Luara I Santos; Fernando S Virgilio; Alexandre V Machado; Oscar Bruna-Romero; Ricardo T Gazzinelli; Mauricio M Rodrigues
Journal:  Hum Gene Ther       Date:  2014-03-31       Impact factor: 5.695

5.  Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.

Authors:  Eiji Takayama; Takeshi Ono; Elena Carnero; Saori Umemoto; Yoko Yamaguchi; Atsuhiro Kanayama; Takemi Oguma; Yasuhiro Takashima; Takushi Tadakuma; Adolfo García-Sastre; Yasushi Miyahira
Journal:  Int J Parasitol       Date:  2010-07-08       Impact factor: 3.981

6.  Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.

Authors:  Leoneide Érica Maduro Bouillet; Mariana Oliveira Dias; Natália Alves Dorigo; Andrew Douglas Moura; Bruce Russell; Francois Nosten; Laurent Renia; Erika Martins Braga; Ricardo Tostes Gazzinelli; Maurício M Rodrigues; Irene S Soares; Oscar Bruna-Romero
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

7.  Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.

Authors:  Wendy G Tan; Hyun-Tak Jin; Erin E West; Pablo Penaloza-MacMaster; Andreas Wieland; Michael J Zilliox; M Juliana McElrath; Dan H Barouch; Rafi Ahmed
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

8.  Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.

Authors:  Gloria González-Aseguinolaza; Yurie Nakaya; Alberto Molano; Edward Dy; Mariano Esteban; Dolores Rodríguez; Juan Ramón Rodríguez; Peter Palese; Adolfo García-Sastre; Ruth S Nussenzweig
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

10.  MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.

Authors:  Tamara K Berthoud; Susanna J Dunachie; Stephen Todryk; Adrian V S Hill; Helen A Fletcher
Journal:  J Immunol Methods       Date:  2008-10-24       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.